CH
CVRS

Canton Hathaway’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Canton Hathaway’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-36,750
Closed -$63K – 278
2019
Q1 		$63K Buy
+36,750
New +$50.8K 0.04% 112

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Canton Hathaway's CVRS Position: Q2 2019 in Review

Canton Hathaway sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2019, closing a stake of 36,750 shares — an estimated $63K sold.

Canton Hathaway first reported a position in CVRS in Q1 2019 and held it in 1 quarter. The position peaked at $63K in Q1 2019. 81 funds tracked by Wall St. Rank hold CVRS as of Q2 2019.

  • Canton Hathaway reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2019 after selling out during the quarter.
  • Canton Hathaway sold 36,750 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2019, an estimated $63K.
  • Canton Hathaway first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2019 and held it in 1 quarter.
  • Canton Hathaway's CORINDUS VASCULAR ROBOTICS, INC position peaked at $63K in Q1 2019.
  • 81 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2019.

Based on Canton Hathaway's 13F filing for Q2 2019, filed 15 Jul 2019.